Bristol-Myers Squibb (BMS) grants Aslan exclusive rights to develop and commercialize BMS-777607 in China, Australia, Korea and Taiwan

Bristol-Myers Squibb Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Aslan Pharmaceuticals Ltd.

Singapore / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced